Closing Soon
Prevention as prevention of Neonatal Hypoglycaemia, sponsored by University of Auckland
Get in touch This trial recruits from July 2013 for 35 weeks
Prof Jane Harding
Phone: +64 9 3737599 ext 85872
Email: j.harding@auckland.ac.nz
Address:
Liggins Institute
2-6 Park Avenue,
Private Bag 92019
Auckland 1142
Inclusion Criteria
Gender: Both males and females
Babies who are at risk of hypoglycaemia, defined as satisfying AT LEAST ONE of the following: 1. Infants of diabetic mothers (any type of diabetes) 2. Preterm (< 37 weeks' gestation) 3. Small (< 2.5kg or < 10th centile on population or customised birthweight chart) 4. Large (> 4.5kg or > 90th centile on population or customised birthweight chart) 5. Other risk e.g. maternal medication
AND satisfy ALL of the following: 1. > or = 35+0 weeks' gestation 2. Birthweight > 2.2kg 3. < 1 hour old 4. No apparent indication for NICU/SCBU admission at time of randomisation 5. Unlikely to require admission to NICU/SCBU for any other reason e.g. respiratory distress 6. Mother intending to breastfeed.
Exclusion Criteria
- Major congenital abnormality
- Previous formula feed or intravenous fluids
- Previous diagnosis of hypoglycaemia
- Admitted to NICU/SCBU
- Imminent admission to NICU/SCBU
ACTRNACTRN12613000322730
In newborn infants at risk of hypoglycaemia does prophylactic oral dextrose gel compared to placebo reduce the incidence of hypoglycaemia (any blood glucose concentration < 2.6 mM).
Hypoglycaemia Prevention in Newborns with Oral Dextrose: the dosage trial